NCT05288803

Brief Summary

This study will examine the impact of a new clinical decision support tool for rehabilitation after total knee arthroplasty (TKA). Typically, TKA rehabilitation is generic with most patients receiving the same dosage and contents of rehabilitation despite notable diversity among patients who undergo TKA. The investigators clinical support decision tool is designed to help physical therapists tailor rehabilitation treatments and dosages to the individual needs, goals, and preferences of Veterans recovering from TKA. This study has the potential to improve Veterans' functional recovery after TKA, while simultaneously reducing the average number of physical therapy visits Veterans attend after surgery by tailoring rehabilitation dosage based upon need. This will ensure the Veterans Health Administration (VHA) has the resources and capacity to provide adequate rehabilitation to every Veteran seeking TKA in the VHA system. Additionally, if successful, this clinical decision support tool could be used to improve outcomes and access for additional patient populations in the future.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
10mo left

Started Apr 2022

Longer than P75 for all trials

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress84%
Apr 2022Mar 2027

First Submitted

Initial submission to the registry

March 10, 2022

Completed
11 days until next milestone

First Posted

Study publicly available on registry

March 21, 2022

Completed
11 days until next milestone

Study Start

First participant enrolled

April 1, 2022

Completed
4.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2026

Expected
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2027

Last Updated

March 25, 2026

Status Verified

March 1, 2026

Enrollment Period

4.5 years

First QC Date

March 10, 2022

Last Update Submit

March 20, 2026

Conditions

Keywords

total knee arthroplastypatient-centered careprecision medicine

Outcome Measures

Primary Outcomes (2)

  • Knee Injury and Osteoarthritis Outcome - Joint Replacement (KOOS, JR)

    The KOOS-JR is a patient-reported measure of physical function developed specifically for patients with total knee arthroplasty. It can be completed quickly (only 7 items) and has established validity, reliability, and responsiveness. KOOS JR will be assessed preoperatively at baseline and re-assessed at 90 (primary timepoint) and 180 days after TKA surgery. KOOS JR will also be assessed postoperatively throughout participants' rehabilitation episode at approximately 2-week intervals up to 180 days after surgery. We will use the interval scoring method for the KOOS JR which ranges from 0 (total knee disability) to 100 (perfect knee health)

    Change in KOOS Jr from preop (baseline) to postop (90 days after TKA surgery)

  • Outpatient Physical Therapy Visit Utilization

    The total outpatient physical therapy visits used in the first 90 postoperative days by each Veteran participant will be extracted from the electronic health record after the Veteran is formally discharged from outpatient rehabilitation. Any visits that occur prior to a Veteran's surgery or in the hospital setting will not count toward the total visit number. We chose postoperative day 90 as our primary endpoint because it corresponds with the average discharge timeframe for outpatient rehabilitation after total knee arthroplasty. Visit utilization will also be assed at at 30, 60, and 180 days after TKA surgery.

    Postoperative day 90

Secondary Outcomes (4)

  • Lower Extremity Functional Scale (LEFS)

    Collected preoperatively at baseline with follow up assessments at 90 and 180 days after TKA surgery

  • Timed Up and Go (TUG)

    Collected preoperatively at baseline and postoperatively at approximately 2-week intervals up to 180 days after TKA surgery

  • Knee range of motion (ROM)

    Collected preoperatively at baseline and postoperatively at approximately 2-week intervals up to 180 days after TKA surgery

  • Western Ontario & McMaster Universities Osteoarthritis Index (WOMAC) Pain subscale

    Collected preoperatively at baseline with one follow up assessment at 90 days after TKA surgery

Other Outcomes (1)

  • Veterans Rand 12-item Health Survey (VR-12)

    Collected preoperatively at baseline with one follow up assessment at 90 days after TKA surgery

Study Arms (2)

Control cohort

The investigators will collect outcomes for 100 Veterans treated with usual care rehabilitation after total knee arthroplasty. Data will be collected at all participating clinical locations. Data collection for these Veterans will precede data collection for the intervention cohort.

Intervention cohort

The investigators will implement the clinical decision support tool in all participating clinic locations. We will collect outcomes for 100 Veterans treated in rehabilitation with use of the clinical decision support tool. Data collection for these Veterans will occur after data collection is complete for the Control cohort.

Other: Clinical decision support tool (CDS tool)

Interventions

The investigators will integrate the CDS tool into clinical practice at each participating clinic after data collection for the Control cohort is complete. All physical therapists at the participating clinic locations will use the CDS tool to inform rehabilitation decision making for Veterans with total knee arthroplasty. The CDS tool will provide personalized information regarding each Veterans' recovery in addition to personalized visit utilization guidelines. Clinicians will use the CDS tool with Veterans at their initial postoperative visits and every 2weeks throughout their course of care thereafter.

Also known as: Knee Recovery Tool
Intervention cohort

Eligibility Criteria

Age40 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Veterans with total knee replacement who seek postoperative outpatient physical therapy treatment at the participating clinics.

You may qualify if:

  • Veterans who have undergone total knee arthroplasty who present for outpatient rehabilitation treatment at the participating clinics within three weeks of surgery.

You may not qualify if:

  • postoperative rehabilitation treatment received in the home health or skilled nursing
  • age \< 40 or \>90

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Rocky Mountain Regional VA Medical Center, Aurora, CO

Aurora, Colorado, 80045-7211, United States

RECRUITING

VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA

Pittsburgh, Pennsylvania, 15240, United States

RECRUITING

Study Officials

  • Jennifer E. Stevens-Lapsley, PhD

    Rocky Mountain Regional VA Medical Center, Aurora, CO

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Jennifer E Stevens-Lapsley, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
FED
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 10, 2022

First Posted

March 21, 2022

Study Start

April 1, 2022

Primary Completion (Estimated)

September 30, 2026

Study Completion (Estimated)

March 31, 2027

Last Updated

March 25, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will share

The research team guarantees that all data collected as part of this project will be released in accordance with standard data sharing policies and procedures to validate research findings if requested. All data released will be de-identified, with no information that could be linked to any study participants (patients and clinicians), or participating study practices to ensure the confidentiality of all participants and practices. If necessary, a data use agreement will be established.

Shared Documents
STUDY PROTOCOL, ICF
Time Frame
Data will be available after the main study results are published.
Access Criteria
Data will be available after the main study results are published for up to 5 years.

Locations